Replicel Life Sciences Inc
XTSX:RP

Watchlist Manager
Replicel Life Sciences Inc Logo
Replicel Life Sciences Inc
XTSX:RP
Watchlist
Price: 0.01 CAD -33.33% Market Closed
Market Cap: 636.6k CAD
Have any thoughts about
Replicel Life Sciences Inc?
Write Note

Replicel Life Sciences Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Replicel Life Sciences Inc
Cash from Financing Activities Peer Comparison

Comparables:
ABCL
ARCH
IOT

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Replicel Life Sciences Inc
XTSX:RP
Cash from Financing Activities
CA$1.9m
CAGR 3-Years
24%
CAGR 5-Years
11%
CAGR 10-Years
6%
Abcellera Biologics Inc
NASDAQ:ABCL
Cash from Financing Activities
$10.4m
CAGR 3-Years
-75%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
Arch Biopartners Inc
XTSX:ARCH
Cash from Financing Activities
CA$1.4m
CAGR 3-Years
-23%
CAGR 5-Years
-3%
CAGR 10-Years
12%
Innovotech Inc
XTSX:IOT
Cash from Financing Activities
CA$104.7k
CAGR 3-Years
-26%
CAGR 5-Years
1%
CAGR 10-Years
0%

See Also

What is Replicel Life Sciences Inc's Cash from Financing Activities?
Cash from Financing Activities
1.9m CAD

Based on the financial report for Sep 30, 2023, Replicel Life Sciences Inc's Cash from Financing Activities amounts to 1.9m CAD.

What is Replicel Life Sciences Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
6%

Over the last year, the Cash from Financing Activities growth was 32%. The average annual Cash from Financing Activities growth rates for Replicel Life Sciences Inc have been 24% over the past three years , 11% over the past five years , and 6% over the past ten years .

Back to Top